SCHEMBL5028992

SCHEMBL5028992

CSc1ccc(Nc2[nH]c(=O)c(Cl)cc2C(=O)N(C)OC[C@H](C)O)c(F)c1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.37
MAP2K2 P36507 1/20 0.36
MAP2K1 Q02750 1/20 0.36
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDM4E B2RXH2 2/20 0.32
HPGD P15428 1/20 0.32
MEN1 O00255 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C19 P33261 1/20 0.30
KMT2A Q03164 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13723742 0.92 MAP2K2 (0.38) KCNH2MAP2K2MAP2K1HPGDGAA
SCHEMBL14920264 0.92 MAP2K2 (0.38) KCNH2MAP2K2MAP2K1HPGDGAA
SCHEMBL5035605 0.88 MAP2K1 (0.40) KCNH2MAP2K2MAP2K1
SCHEMBL5028995 0.88 MAP2K2 (0.39) KCNH2MAP2K2MAP2K1HPGDGAA
SCHEMBL5028996 0.83 HSD17B10 (0.39) KCNH2MAP2K2MAP2K1TSHRHTT
SCHEMBL5029001 0.79 MAP2K1 (0.39) MAP2K2MAP2K1HPGDGAA
SCHEMBL5031221 0.79 MAP2K1 (0.42) KCNH2MAP2K2MAP2K1
SCHEMBL5031300 0.78 MAP2K1 (0.35) KCNH2MAP2K2MAP2K1CYP1A2
SCHEMBL5035606 0.75 MAP2K1 (0.46) MAP2K2MAP2K1CYP3A4CYP2C19
SCHEMBL5029045 0.75 MAP2K1 (0.40) MAP2K2MAP2K1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1922307-A2 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF Array Biopharma, Inc. (US) 2008-05-21 EP claimed
WO-2007044084-A2 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC. (US) 2007-04-19 WO claimed